About Galantos Pharma

About company

Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer's and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer's dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.